Pharmaceuticals

Transdermal Skin Patches Market Revenue Outlook: Strategic Insights and Forecast to 2029

September 1, 2025 by Marketing Posting

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#How Much Is the Global Transdermal Skin Patches Market Valued at Present and by 2029?#_x000D_

The market for breast cancer medication has experienced solid growth in recent times, with forecasts predicting an increase from $39.58 billion in 2024 to $42.45 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.3%. The expansion during the historical period can be linked to factors such as a rising prevalence of breast cancer, advancements in investigative studies and development, the implementation of early detection stratagem, progress in treatment guidelines, and the growth of healthcare facilities._x000D_

_x000D_

The market size for drugs combating breast cancer is projected to witness significant advancement in the ensuing years, reaching “$56.81 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 7.6%. Factors contributing to this growth during the forecast period include the accelerating aging population, burgeoning markets, supportive legislations, and enhanced patient advocacy and awareness. Foreseen trends in the prediction period comprise of personalized medicine, targeted therapies, immunotherapies, clinical research, drug pipeline developments, combination treatment methods, biomarker-oriented treatments, telemedicine, and distant monitoring._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=2566&type=smp_x000D_

_x000D_

#What Drivers Are Influencing Growth In The Transdermal Skin Patches Market?_x000D_

The predicted rise in the incidence of cardiovascular disease is expected to drive the transdermal skin patches market’s development. These diseases affecting the heart and blood vessels are generally accompanied by accumulation of fatty deposits within the arteries (atherosclerosis) and increased susceptibility to blood clots. Transdermal skin patches play a critical role in preventing angina episodes among individuals with coronary artery disease, which involves the narrowing of blood vessels that provide blood to the heart. They are also utilized to enhance bioavailability in heart failure management. For example, a report released by the American College of Cardiology in August 2022 forecasts a growing trend in all four cardiovascular risk factors in the United States from 2025 to 2060. Diabetes is predicted to ascend by 39.3% to 55 million people, the highest rate, followed by dyslipidemia (an increase of 27.6% to 126 million), hypertension (a raise of 25.1% to 162 million), and obesity (an surge of 18.3% to 126 million). The study also indicated that stroke (a rise of 33.8% to 15 million) and heart failure (an increase of 33.4% to 13 million) exhibited the most significant expected augmentation in cardiovascular disease rates, followed by ischemic heart disease (an increase of 30.7% to 29 million) and heart attack (a surge of 16.9% to 16 million). Hence, this growing trend in cardiovascular disease prevalence is boosting the transdermal skin patches market._x000D_

_x000D_

The breast cancer drugs market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Metastatic Breast Cancer, Triple Negative Breast Cancer, Others (Ductal Carcinoma Insitu, Invasive Ductal Carcinoma, Inflammatory Breast Cancer, Breast Cancer During Pregnancy, Others)_x000D_

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribution Channels_x000D_

3) By End User: Ambulatory, Hospitals, Clinics, Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Metastatic Breast Cancer: Hormone Receptor Positive Metastatic Breast Cancer, HER2 Positive Metastatic Breast Cancer, Triple Negative Metastatic Breast Cancer _x000D_

2) By Triple Negative Breast Cancer: Chemotherapy-Based Treatments, Immunotherapy-Based Treatments, Targeted Therapy _x000D_

3) By Others: Ductal Carcinoma In Situ (DCIS), Invasive Ductal Carcinoma (IDC), Inflammatory Breast Cancer (IBC), Breast Cancer During Pregnancy, Other Subtypes (Lobular Carcinoma, Paget’s Disease of the Breast)_x000D_

_x000D_

#What Future Market Trends Are Projected For The Transdermal Skin Patches Industry?#_x000D_

Breast cancer drug makers are progressively entering into partnerships or collaborations with other firms to pool technological assets, resources, and product expertise to broaden their operations. As an example, AstraZeneca signed a collaboration agreement valued at $6.9 billion for the creation of a breast cancer medication. The agreement stipulates that the companies will collectively develop the drug trastuzumab deruxtecan and will equally split the development and dissemination costs for the drug on a global scale. Novartis teamed up with IBM Watson Health to create a solution that can identify the optimum sequences and combination of drugs for improving patient results._x000D_

_x000D_

#Which Companies Play A Key Role In The Development Of The Transdermal Skin Patches Market?#_x000D_

Major companies operating in the breast cancer drugs market include F. Hoffmann-La Roche Ltd., Novartis AG, AstraZeneca PLC, Eli Lilly and Company Inc., Biocon Limited, Merck & Co. Inc., Genzyme Corporation, Johnson & Johnson, MacroGenics Inc., Celldex Therapeutics Inc., Onyx Pharmaceuticals Inc., BioNumerik Pharmaceuticals Inc., AbbVie Inc., Pfizer Inc., OncoGenex Pharmaceuticals Inc., Astellas Pharma Inc., Bristol-Myers Squibb Company, Bayer AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Abbott Laboratories, Apthera Inc., Oncothyreon Inc., BiPar Sciences Inc., Puma Biotechnology Inc., Sanofi S.A., Genentech Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Eisai Co. Ltd., Mylan N.V., Dr. Reddy’s Laboratories Ltd., Accord Healthcare Limited, Alkem Laboratories Limited, Natco Pharma Limited, Fresenius Kabi AG, Lupin Limited, Glenmark Pharmaceuticals Limited_x000D_

_x000D_

https://www.thebusinessresearchcompany.com/report/breast-cancer-drugs-global-market-report_x000D_

_x000D_

#What Are The Key Regional Developments Shaping The Transdermal Skin Patches Market?#_x000D_

North America was the largest region in the breast cancer drugs market in 2024. The Middle East is expected to be the fastest-growing region in the breast cancer drugs market during the forecast period. The regions covered in the breast cancer drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=2566&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_